143 related articles for article (PubMed ID: 3760959)
1. Detection of human glioma-associated antigen by rat monoclonal antibody raised against syngeneic rat glioma cells.
Saya H; Masuko T; Kokunai T; Yagita H; Ijichi A; Taomoto K; Tamaki N; Matsumoto S; Hashimoto Y
J Neurosurg; 1986 Oct; 65(4):495-502. PubMed ID: 3760959
[TBL] [Abstract][Full Text] [Related]
2. Derivation of a brain tumor-selective monoclonal antibody from hybridoma between mouse myeloma and rat spleen cells immune to syngeneic glioma.
Saya H; Masuko T; Hashimoto Y
Jpn J Cancer Res; 1985 Dec; 76(12):1198-202. PubMed ID: 3937832
[TBL] [Abstract][Full Text] [Related]
3. Characterization of neuroectodermal antigen by a monoclonal antibody and its application in CSF diagnosis of human glioma.
Wakabayashi T; Yoshida J; Seo H; Kazo K; Murata Y; Matsui N; Kageyama N
J Neurosurg; 1988 Mar; 68(3):449-55. PubMed ID: 3343615
[TBL] [Abstract][Full Text] [Related]
4. Antigenic heterogeneity of human brain tumors defined by monoclonal antibodies.
Stavrou D; Bise K; Groeneveld J; Stocker U; Kretzschmar HA; Keiditsch E; Mehraein P
Anticancer Res; 1989; 9(6):1489-96. PubMed ID: 2697177
[TBL] [Abstract][Full Text] [Related]
5. Human glioma-mesenchymal extracellular matrix antigen defined by monoclonal antibody.
Bourdon MA; Wikstrand CJ; Furthmayr H; Matthews TJ; Bigner DD
Cancer Res; 1983 Jun; 43(6):2796-805. PubMed ID: 6342760
[TBL] [Abstract][Full Text] [Related]
6. Glioma-associated antigens defined by monoclonal antibodies against an avian sarcoma virus-induced rat astrocytoma.
Lee YS; Wikstrand CJ; Bigner DD
J Neuroimmunol; 1986 Dec; 13(2):183-202. PubMed ID: 2430997
[TBL] [Abstract][Full Text] [Related]
7. Antigen related to cell proliferation in malignant gliomas recognized by a human monoclonal antibody.
Kokunai T; Tamaki N; Matsumoto S
J Neurosurg; 1990 Dec; 73(6):901-8. PubMed ID: 2230972
[TBL] [Abstract][Full Text] [Related]
8. Monoclonal antibodies reactive with glioma cell lines derived from experimental brain tumors.
Stavrou D; Süss C; Bilzer T; Kummer U; De Tribolet N
Eur J Cancer Clin Oncol; 1983 Oct; 19(10):1439-49. PubMed ID: 6196200
[TBL] [Abstract][Full Text] [Related]
9. Demonstration of complex antigenic heterogeneity in a human glioma cell line and eight derived clones by specific monoclonal antibodies.
Wikstrand CJ; Bigner SH; Bigner DD
Cancer Res; 1983 Jul; 43(7):3327-34. PubMed ID: 6303581
[TBL] [Abstract][Full Text] [Related]
10. Monoclonal antibodies against human astrocytomas and their reactivity pattern.
Stavrou D; Keiditsch E; Schmidberger F; Bise K; Funke I; Eisenmenger W; Kurrle R; Martin B; Stocker U
J Neurol Sci; 1987 Sep; 80(2-3):205-20. PubMed ID: 3316507
[TBL] [Abstract][Full Text] [Related]
11. Evaluation of the humoral response of glioma patients to a possible common tumor-associated antigen(s).
Martin-Achard A; Diserens AC; de Tribolet N; Carrel S
Int J Cancer; 1980 Feb; 25(2):219-24. PubMed ID: 7390650
[TBL] [Abstract][Full Text] [Related]
12. Antitumor activity against established intracerebral gliomas exhibited by cytotoxic T lymphocytes, but not by lymphokine-activated killer cells.
Holladay FP; Heitz T; Wood GW
J Neurosurg; 1992 Nov; 77(5):757-62. PubMed ID: 1403119
[TBL] [Abstract][Full Text] [Related]
13. Monoclonal antibodies against cell surface antigens present on human urinary bladder cancer cells.
Masuko T; Yagita H; Hashimoto Y
J Natl Cancer Inst; 1984 Mar; 72(3):523-30. PubMed ID: 6583438
[TBL] [Abstract][Full Text] [Related]
14. Differential antigenic expression of the DBA/2 lymphoma L1210 and its sublines: cross-reactivity with C3H mammary tumors as defined by syngeneic monoclonal antibodies.
Rapp L; Fuji H
Cancer Res; 1983 Jun; 43(6):2592-9. PubMed ID: 6342755
[TBL] [Abstract][Full Text] [Related]
15. Murine monoclonal IgG3 antibodies to human colorectal tumor-associated antigens: production and characterization of antibodies active in both antibody-dependent cellular cytotoxicity and complement-mediated cytolysis.
Woodhouse CS; Morgan AC
Cancer Res; 1989 May; 49(10):2766-72. PubMed ID: 2713860
[TBL] [Abstract][Full Text] [Related]
16. Treatment of intracranial gliomas with bone marrow-derived dendritic cells pulsed with tumor antigens.
Liau LM; Black KL; Prins RM; Sykes SN; DiPatre PL; Cloughesy TF; Becker DP; Bronstein JM
J Neurosurg; 1999 Jun; 90(6):1115-24. PubMed ID: 10350260
[TBL] [Abstract][Full Text] [Related]
17. Surface antigenic characteristics of human glial brain tumor cells.
Wikstrand CJ; Mahaley MS; Bigner DD
Cancer Res; 1977 Dec; 37(12):4267-75. PubMed ID: 72598
[TBL] [Abstract][Full Text] [Related]
18. Monoclonal antibodies against cell-surface antigens of the metastatic rat 13762NF mammary adenocarcinoma and their cross-reactivity with human breast carcinomas.
North SM; Steck PA; Nicolson GL
Cancer Res; 1986 Dec; 46(12 Pt 1):6393-9. PubMed ID: 3779654
[TBL] [Abstract][Full Text] [Related]
19. Monoclonal antibody T-199 directed against human medulloblastoma: characterization of a new antigenic system expressed on neuroectodermal tumors and natural killer cells.
Feickert HJ; Pietsch T; Hadam MR; Mildenberger H; Riehm H
Cancer Res; 1989 Aug; 49(15):4338-43. PubMed ID: 2743322
[TBL] [Abstract][Full Text] [Related]
20. Monoclonal antibodies with cytotoxic reactivities against human gliomas.
Nanda A; Liwnicz B; Atkinson BF; Sela BA; Takahashi H; Belser PH; Black P; Koprowski H; Herlyn D
J Neurosurg; 1989 Dec; 71(6):892-7. PubMed ID: 2585082
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
